160 related articles for article (PubMed ID: 17105432)
1. The development of preventives and therapeutics for Alzheimer's disease that inhibit the formation of beta-amyloid fibrils (fAbeta), as well as destabilize preformed fAbeta.
Ono K; Naiki H; Yamada M
Curr Pharm Des; 2006; 12(33):4357-75. PubMed ID: 17105432
[TBL] [Abstract][Full Text] [Related]
2. Anti-amyloidogenic effects of antioxidants: implications for the prevention and therapeutics of Alzheimer's disease.
Ono K; Hamaguchi T; Naiki H; Yamada M
Biochim Biophys Acta; 2006 Jun; 1762(6):575-86. PubMed ID: 16644188
[TBL] [Abstract][Full Text] [Related]
3. Potent anti-amyloidogenic and fibril-destabilizing effects of polyphenols in vitro: implications for the prevention and therapeutics of Alzheimer's disease.
Ono K; Yoshiike Y; Takashima A; Hasegawa K; Naiki H; Yamada M
J Neurochem; 2003 Oct; 87(1):172-81. PubMed ID: 12969264
[TBL] [Abstract][Full Text] [Related]
4. Anti-amyloidogenic activity of tannic acid and its activity to destabilize Alzheimer's beta-amyloid fibrils in vitro.
Ono K; Hasegawa K; Naiki H; Yamada M
Biochim Biophys Acta; 2004 Nov; 1690(3):193-202. PubMed ID: 15511626
[TBL] [Abstract][Full Text] [Related]
5. Curcumin has potent anti-amyloidogenic effects for Alzheimer's beta-amyloid fibrils in vitro.
Ono K; Hasegawa K; Naiki H; Yamada M
J Neurosci Res; 2004 Mar; 75(6):742-50. PubMed ID: 14994335
[TBL] [Abstract][Full Text] [Related]
6. Nicotine breaks down preformed Alzheimer's beta-amyloid fibrils in vitro.
Ono K; Hasegawa K; Yamada M; Naiki H
Biol Psychiatry; 2002 Nov; 52(9):880-6. PubMed ID: 12399141
[TBL] [Abstract][Full Text] [Related]
7. Preformed beta-amyloid fibrils are destabilized by coenzyme Q10 in vitro.
Ono K; Hasegawa K; Naiki H; Yamada M
Biochem Biophys Res Commun; 2005 Apr; 330(1):111-6. PubMed ID: 15781239
[TBL] [Abstract][Full Text] [Related]
8. Nordihydroguaiaretic acid potently breaks down pre-formed Alzheimer's beta-amyloid fibrils in vitro.
Ono K; Hasegawa K; Yoshiike Y; Takashima A; Yamada M; Naiki H
J Neurochem; 2002 May; 81(3):434-40. PubMed ID: 12065652
[TBL] [Abstract][Full Text] [Related]
9. Ferulic acid destabilizes preformed beta-amyloid fibrils in vitro.
Ono K; Hirohata M; Yamada M
Biochem Biophys Res Commun; 2005 Oct; 336(2):444-9. PubMed ID: 16153607
[TBL] [Abstract][Full Text] [Related]
10. Anti-amyloidogenic therapies: strategies for prevention and treatment of Alzheimer's disease.
Hamaguchi T; Ono K; Yamada M
Cell Mol Life Sci; 2006 Jul; 63(13):1538-52. PubMed ID: 16804637
[TBL] [Abstract][Full Text] [Related]
11. Binding of proteases to fibrillar amyloid-beta protein and its inhibition by Congo red.
Chander H; Chauhan A; Chauhan V
J Alzheimers Dis; 2007 Nov; 12(3):261-9. PubMed ID: 18057560
[TBL] [Abstract][Full Text] [Related]
12. Pharmacodynamics in Alzheimer's disease model rats of a bifunctional peptide with the potential to accelerate the degradation and reduce the toxicity of amyloid β-Cu fibrils.
Wang D; Zhang Q; Hu X; Wang W; Zhu X; Yuan Z
Acta Biomater; 2018 Jan; 65():327-338. PubMed ID: 29111371
[TBL] [Abstract][Full Text] [Related]
13. Matrix metalloproteinase-9 degrades amyloid-beta fibrils in vitro and compact plaques in situ.
Yan P; Hu X; Song H; Yin K; Bateman RJ; Cirrito JR; Xiao Q; Hsu FF; Turk JW; Xu J; Hsu CY; Holtzman DM; Lee JM
J Biol Chem; 2006 Aug; 281(34):24566-74. PubMed ID: 16787929
[TBL] [Abstract][Full Text] [Related]
14. Anti-Parkinsonian agents have anti-amyloidogenic activity for Alzheimer's beta-amyloid fibrils in vitro.
Ono K; Hasegawa K; Naiki H; Yamada M
Neurochem Int; 2006 Mar; 48(4):275-85. PubMed ID: 16343694
[TBL] [Abstract][Full Text] [Related]
15. The anti-amyloidogenic effect is exerted against Alzheimer's beta-amyloid fibrils in vitro by preferential and reversible binding of flavonoids to the amyloid fibril structure.
Hirohata M; Hasegawa K; Tsutsumi-Yasuhara S; Ohhashi Y; Ookoshi T; Ono K; Yamada M; Naiki H
Biochemistry; 2007 Feb; 46(7):1888-99. PubMed ID: 17253770
[TBL] [Abstract][Full Text] [Related]
16. S14G-humanin inhibits Aβ1-42 fibril formation, disaggregates preformed fibrils, and protects against Aβ-induced cytotoxicity in vitro.
Zhang W; Du Y; Bai M; Xi Y; Li Z; Miao J
J Pept Sci; 2013 Mar; 19(3):159-65. PubMed ID: 23349038
[TBL] [Abstract][Full Text] [Related]
17. Estrogen has anti-amyloidogenic effects on Alzheimer's beta-amyloid fibrils in vitro.
Morinaga A; Hirohata M; Ono K; Yamada M
Biochem Biophys Res Commun; 2007 Aug; 359(3):697-702. PubMed ID: 17559807
[TBL] [Abstract][Full Text] [Related]
18. Alpha-lipoic acid exhibits anti-amyloidogenicity for beta-amyloid fibrils in vitro.
Ono K; Hirohata M; Yamada M
Biochem Biophys Res Commun; 2006 Mar; 341(4):1046-52. PubMed ID: 16460684
[TBL] [Abstract][Full Text] [Related]
19. Blood-borne factors inhibit Alzheimer's beta-amyloid fibril formation in vitro.
Ono K; Noguchi-Shinohara M; Samuraki M; Matsumoto Y; Yanase D; Iwasa K; Naiki H; Yamada M
Exp Neurol; 2006 Nov; 202(1):125-32. PubMed ID: 16806179
[TBL] [Abstract][Full Text] [Related]
20. Dimeric bis (heptyl)-Cognitin Blocks Alzheimer's β-Amyloid Neurotoxicity Via the Inhibition of Aβ Fibrils Formation and Disaggregation of Preformed Fibrils.
Hu SQ; Wang R; Cui W; Mak SH; Li G; Hu YJ; Lee MY; Pang YP; Han YF
CNS Neurosci Ther; 2015 Dec; 21(12):953-61. PubMed ID: 26507365
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]